Actively Recruiting
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Led by Marshall University · Updated on 2025-05-13
60
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
CONDITIONS
Official Title
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
- English speaking
- 18-45 years old
- Willing to provide informed consent
- Gestational age prior to 15 weeks gestation
You will not qualify if you...
- Non-English speaking patients
- Younger than 18 years old or older than 45 years old
- Not willing or able to provide consent
- Gestational age greater than 15 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maternal Hypertension Center at Cabell Huntington Hospital
Huntington, West Virginia, United States, 25701
Actively Recruiting
Research Team
M
Morgan Ruley, MS
CONTACT
J
Jesse Cottrell, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here